These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12855141)

  • 21. [Drug Design].
    Abanades S; Farré M
    Med Clin (Barc); 2003 Jun; 121(1):38. PubMed ID: 12812711
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute hepatitis due to ingestion of Ecstasy].
    Huarte Muniesa MP; Pueyo Royo AM
    Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for fulminant hepatitis A infection.
    Mishra D; Singh R; Sibal A
    Indian Pediatr; 2002 Feb; 39(2):189-92. PubMed ID: 11867852
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDMA ("ecstasy") and neurotoxicity.
    Mithoefer M; Jerome L; Doblin R
    Science; 2003 Jun; 300(5625):1504-5; author reply 1504-5. PubMed ID: 12791964
    [No Abstract]   [Full Text] [Related]  

  • 27. Modelling the adverse effects associated with ecstasy use.
    Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
    Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute hepatitis induced by Ecstasy].
    Indart Pérez A; Mendia Gorostidi A; Barrio Andrés J; Arens Miravé I
    Gastroenterol Hepatol; 1998 Dec; 21(10):499. PubMed ID: 9927798
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Ecstasy"-induced hepatitis in an active duty soldier.
    Hwang I; Daniels AM; Holtzmuller KC
    Mil Med; 2002 Feb; 167(2):155-6. PubMed ID: 11873540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press.
    Green AR
    Psychopharmacology (Berl); 2004 May; 173(3-4):231-3. PubMed ID: 14985917
    [No Abstract]   [Full Text] [Related]  

  • 33. Ecstasy induced fatal hepatic failure.
    Colak Y; Tuncer I; Enc FY; Ozturk O; Kiziltas S; Ulasoglu C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):215-6. PubMed ID: 21725523
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.
    Sumnall HR; Jerome L; Doblin R; Mithoefer MC
    Psychopharmacology (Berl); 2004 Jan; 171(2):229-30. PubMed ID: 14634709
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis from ecstasy].
    Giner Durán R; Flors H; Millán M; Manzanera R
    Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fatal ecstasy intoxication in a 22-year-old man].
    Schilder JN
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2295; author reply 2295. PubMed ID: 17987903
    [No Abstract]   [Full Text] [Related]  

  • 37. Ecstasy: a common cause of severe acute hepatotoxicity.
    Andreu V; Mas A; Bruguera M; Salmerón JM; Moreno V; Nogué S; Rodés J
    J Hepatol; 1998 Sep; 29(3):394-7. PubMed ID: 9764985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hallucinogen persisting perception disorder after ecstasy use].
    Hanck L; Schellekens AF
    Ned Tijdschr Geneeskd; 2013; 157(24):A5649. PubMed ID: 23759176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of drug-facilitated sexual assault involving 3,4-methylenedioxy-methylamphetamine.
    Eiden C; Cathala P; Fabresse N; Galea Y; Mathieu-Daudé JC; Baccino E; Peyrière H
    J Psychoactive Drugs; 2013; 45(1):94-7. PubMed ID: 23662335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple organ failure associated with use of ecstasy].
    Trejo Gutiérrez O; Ortega Romero M; Perea Gainza M; Nogué Xarau S
    Rev Clin Esp; 2001 Feb; 201(2):108-9. PubMed ID: 11345602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.